COPD: Inhaled Strategies in the Clinic

Volume 1, Issue 4

COPD: Inhaled Strategies in the Clinic

Learning objectives:

Discuss the evidence describing the preferred treatment for symptomatic patients with COPD who have a low risk of exacerbations.
Describe the evidence for the preferred treatment strategy for patients with GOLD grade D COPD.
Explain the role of supplemental oxygen therapy in patients with COPD.

Author:

Nadia N. Hansel, MD, MPH

Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Guest Faculty Disclosures

Dr. Hansel has indicated that she has received gifts in kind from Austin Air and consulting fees from GlaxoSmithKline, and has performed contracted research for AstraZeneca and Boehringer Ingelheim Vetmedica GmbH.

Unlabeled/Unapproved Uses

Dr. Hansel has indicated there will be no references to unlabeled or unapproved uses of drugs or products in this presentation.

Program Directors:

Gregory B. Diette, MD

Professor of Medicine, Epidemiology and Environmental Health Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland

Christine Smith, RN, MSN

Senior Clinic Nurse Coordinator
Johns Hopkins Medicine
Baltimore, Maryland

Guest Faculty Disclosures:

Unlabeled/Unapproved Uses:

Dr. Hansel has indicated there will be no references to unlabeled or unapproved uses of drugs or products in this presentation.

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: June 8, 2018
Expiration date: June 7, 2020

Start Issue